First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
J Clin Pharmacol
; 59(12): 1669-1677, 2019 12.
Article
in En
| MEDLINE
| ID: mdl-31243790
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carboxypeptidase B2
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Pharmacol
Year:
2019
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido